openPR Logo
Press release

Over-the-counter (OTC) Drugs Market Top Trends 2027 | Bayer, Johnson & Johnson, Sanofi, GlaxoSmithKline

05-04-2021 06:04 AM CET | Health & Medicine

Press release from: Global Market Insight, Inc

Over-the-counter (OTC) Drugs Market Top Trends 2027 | Bayer,

Over-the-counter (OTC) Drugs Market report offers in-depth analysis of the industry size, share, major segments, and different geographic regions, forecast for the next five years, key market players, and premium industry trends. It also focuses on the key drivers, restraints, opportunities and industry challenges.

As there has been a considerable shift towards self-medication across several developing as well as developed nations, manufacturers are increasingly shifting from Rx to OTC drugs which is projected to bring major impetus to the global Over-the-Counter drugs market over the ensuing years. Furthermore, with the worldwide outbreak of COVID-19 pandemic, people are laying immense focus on personal health which has fueled the demand for over-the-counter supplements of vitamin and mineral, common flu and cold products, etc. This has positively influenced the business space in recent times. According to a recent report by Global Market Insights, Inc., Over-the-Counter (OTC) drugs market had recorded a valuation of over USD 151.7 billion in 2020 and is estimated to observe a robust CAGR of 5.1% through 2027.

Request for a sample copy of this report @

Top Industry Players –
• Johnson & Johnson,
• Bayer,
• GlaxoSmithKline,
• Sanofi,
• Dr. Reddy’s Laboratories
• Cipla

In addition, usage of over the counter drugs medication helps in saving cost associated to the treatment drugs and clinic visits. These drugs are useful in the treatment of wide range of common conditions such as flu, cold, vitamin deficiency and skin conditions.

Further, strategic initiatives by prominent players operating in the industry including Pfizer, Bayer, GlaxoSmithKline, Johnson & Johnson, Takeda, Sanofi, Cipla, etc. are also playing a key role in expanding the market space. For instance, in 2019, Sanofi inked an agreement with Roche for exclusive Over-the-Counter rights for Tamiflu® for preventing and treating influenza in the US. As per the agreement terms, Sanofi was named to lead FDA negotiations for the OTC switch along with the subsequent marketing campaigns, scientific engagement and distribution of Tamiflu OTC across the country.

An overview of some of the important segments that are likely to transform the outlook of OTC drugs market is as under:

Based on the product bifurcation, cold, cough and flu segment had registered an appreciable valuation of about USD 31.8 billion in 2020 and is expected to grow exponentially over the coming years. The growth can be attributed to increasing product adoption due to frequent incidences of cold and flu among the global population. In fact, as per the Centers for Disease Control and Prevention report, millions of cases of common cold are reported almost every year in the U.S. Besides, an increase in the number of patients suffering from seasonal flu from climatic and weather changes is as well fueling the adoption of OTC medicines and drugs.

Based on regional outlook, OTC drugs industry across Asia Pacific had secured a sizeable revenue share of over 37.7% in 2020 and is anticipated to observe a meritorious growth over the forthcoming years owing to elevating product demand driven by increasing prevalence of seasonal influenza and flu in the region. As per the National Centre for Disease Control (NCDC) statistics, India had recorded total 6701 cases of H1N1 in 2019.

Request for customization @

Moreover, presence of eminent manufacturers who are inclined on expanding their business in the region will complement the market growth further. Quoting an instance, in 2019, the Competition Commission of India had approved the joint venture of two eminent pharmaceutical companies namely Pfizer and GlaxoSmithKline for the distribution of OTC drugs and healthcare supplements across India.

Partial Chapter of the Table of Content

Chapter 2 Executive Summary

2.1 Over-the-counter (OTC) drugs industry 3600 synopsis, 2016 – 2027 (USD Billion)

2.1.1 Business trends

2.1.2 Product trends

2.1.3 Regional trends

Chapter 3 Over-the-counter (OTC) Drugs Industry Insights

3.1 Industry segmentation

3.2 Industry landscape, 2016 - 2027

3.3 Industry impact forces

3.3.1 Growth drivers Pharmaceutical companies switching from Rx to OTC drugs especially in the U.S. Growing trend of self-medication in developing economies Significant cost savings due to OTC drug usage in Asia pacific and Latin America

3.3.2 Industry pitfalls & challenges Several concerns pertaining to incorrect diagnosis and substance abuse

3.4 Growth potential analysis

3.4.1 By product

3.5 COVID-19 impact analysis

3.6 Regulatory landscape

3.6.1 U.S.

3.6.2 Europe

3.7 Porter's analysis

3.8 Competitive landscape, 2020

3.9 PESTEL analysis

Browse full table of contents (TOC) of this report @

Contact Us:
Arun Hegde
Corporate Sales, USA
Global Market Insights, Inc.
Phone: 1-302-846-7766
Toll Free: 1-888-689-0688

About Global Market Insights, Inc.
Global Market Insights, Inc., headquartered in Delaware, U.S., is a global market research and consulting service provider, offering syndicated and custom research reports along with growth consulting services. Our business intelligence and industry research reports offer clients with penetrative insights and actionable market data specially designed and presented to aid strategic decision making. These exhaustive reports are designed via a proprietary research methodology and are available for key industries such as chemicals, advanced materials, technology, renewable energy, and biotechnology.

This release was published on openPR.

Permanent link to this press release:

Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Over-the-counter (OTC) Drugs Market Top Trends 2027 | Bayer, Johnson & Johnson, Sanofi, GlaxoSmithKline here

News-ID: 2279234 • Views: 908

More Releases from Global Market Insight, Inc

Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Halocarbon Products
Inhalation Anesthesia Market Projections 2025 | Abbott, Baxter International, Ha …
Global inhalation anesthesia market is poised to gain massive momentum over the forecast period of 2019 to 2025. This can be credited to the significant rise in product adoption primarily driven by increasing surgical procedures related to respiratory, neurological and chronic disorders. Additionally, supportive reimbursement scenario across developed countries and availability of several insurance schemes for quick and affordable surgical procedures will increase the application of inhalational anesthetics, thereby supporting
Health Insurance Market Trends 2025 | Aetna, Blue Cross Blue Shield Companies, Cigna, Highmark, HCSC
Health Insurance Market Trends 2025 | Aetna, Blue Cross Blue Shield Companies, C …
Regular occurrences of long-term diseases will bolster the health insurance industry trends in the next few years. This rise can be attributed to the changing dietary habits, lack of physical activities, poor nutrition, excessive alcohol use, and tobacco consumption. Various Government-backed initiatives by several programs like State Children's Health Insurance Program, Medicaid, Life programs, Department of Defense, TRICARE are employed to provide health insurance policies. Centers for Medicare & Medicaid
Ambulance Services Market Outlook 2021-2026 | Acadian Ambulance Service, BVG India Limited
Ambulance Services Market Outlook 2021-2026 | Acadian Ambulance Service, BVG Ind …
The global ambulance services market is estimated to foresee momentous growth through the forthcoming time period owing to an upsurge in road accidents. Additionally, the growing prevalence of chronic diseases and increasing medical tourism trend is further slated to augment the overall market size through 2026. Additionally, the introduction of new ambulance models and launch of new technologies that focus on the enhancement of ambulatory care is likely to proliferate
Biosimilars Market Forecast 2025 | Amgen, Biocon, Biogen, Boehringer Ingelheim, Celltrion, Coherus BioSciences
Biosimilars Market Forecast 2025 | Amgen, Biocon, Biogen, Boehringer Ingelheim, …
Touted to be an intrinsic sub-vertical of healthcare and medical devices industry, biosimilars market is poised to record phenomenal gains in the upcoming years owing to the fact that these play a pivotal role in augmenting public health issue by addressing the customer needs to a much larger extent. Numerous reports suggest that biosimilars would result in overall potential savings of nearly USD 100 billion by the end of 2020,

All 5 Releases

More Releases for OTC

Deadline on Nov. 9th upcoming in Lawsuit for Investors in Harborside Inc. (OTC: …
The Shareholders Foundation announced that a deadline is coming up on November 9, 2020 in the lawsuit filed for certain investors of Harborside Inc. (OTC: HSDEF, OTC: HBORF). Investors who purchased shares of Harborside Inc. (OTC: HSDEF, OTC: HBORF) have certain options and there are strict and short deadlines running. Deadline: November 9, 2020. Harborside Inc. stockholders should contact the Shareholders Foundation at or call +1(858) 779 - 1554. According to
Investigation for Long-Term Investors in shares of Volkswagen AG (OTC: VWAGY / O …
An investigation on behalf of current long-term investors in shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) was announced over potential breaches of fiduciary duties by certain officers and directors at Volkswagen AG. Investors who purchased shares of Volkswagen AG (OTC: VWAGY / OTC: VLKAF / OTC: VWAPY) and currently hold any of those Volkswagen AG shares have certain options and should contact the Shareholders Foundation at
OTC: VWAGY / OTC: VLKAF / OTC: VWAPY Shareholder Notice: Update in Lawsuit again …
The Shareholders Foundation, Inc. announces that a lawsuit is pending for certain investors in Volkswagen AG (OTC: VWAGY) (OTC: VWAPY) shares. Investors, who purchased shares of Volkswagen AG (OTC: VWAGY) (OTC: VLKAF) (OTC: VWAPY), have certain options and should contact the Shareholders Foundation at or call +1(858) 779 - 1554. On September 25, 2015, a lawsuit was filed against Volkswagen AG (alleged securities laws violations. The plaintiff claimed that the defendants
OTC Analgesics Market OTC analgesics market is projected to register a steady ex …
About OTC Analgesics Market The global OTC analgesics market is projected to register an above-average CAGR during 2017 to 2022. Global sales of OTC analgesics is estimated to account for nearly US$ 25,000 Mn revenues by 2022-end. Get Sample copy of this Report @ The trend of using off-label drugs that are affordable and unapproved, but effective in treating diseases, has been witnessing an upsurge over the past few years.
03-14-2018 | Health & Medicine
OTC Analgesics Market Report 2017-22: Pharmacy to Remain the Most Lucrative OTC …
A fresh study, covering “OTC Analgesics Market Forecast, Trend Analysis & Competition Tracking – Global Review 2017 to 2022” has been broadcasted to wide online repository of Fact MR, which presents deep focus on the healthcare market. This smart study contains precise data that offers a clear insight about market current scenario and future projections for the benefit of readers. Moreover, the study enclosed significant data which tends to make
The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects has announced the addition of the “Global OTC Drugs Market Research Report 2017” The report focuses on global major leading industry players with information such as company profiles, product picture and specification. GBI Research's latest report, "The OTC Drugs Market: Commercial Trends and Rx-to-OTC Switch Prospects" discusses trends in the over-the-counter (OTC) pharmaceuticals market and the commercial prospects for switching drugs from prescription-only to OTC status. The report assesses current